01 — Financials
Financial overview
Revenue
NOK 2,251,140
Period ending 2024-12-31
Operating profit
NOK 50,536
Profit before tax
NOK 1,648,681
Net profit
NOK 1,648,681
Total assets
NOK 15,709,525
Equity
NOK 15,313,389
Latest reporting period ending 2024-12-31
02 — Signals & news
Recent activity
No signals tracked yet
Funding rounds, hiring activity, and leadership changes will appear here when detected
Set up alerts for this company
Get notified about funding, hiring, and leadership changes
03 — Get in touch
Reach SKANDINAVISK REVMATOLOGISK FORSKNING STI
Key people
Eline Lundgaard
Daglig leder
Espen Andre Haavardsholm
Styre
Anne Margrethe Troldborg
Styre
Vappu Marianna Rantalaiho
Styre
Jon Fredrik Lampa
Styre
Draft an intro emailpro
AI-generated contextual outreach
Prepare a meeting briefpro
One-page summary for your next call
Find decision-makerspro
Search by role and seniority
04 — Similar companies
Companies like SKANDINAVISK REVMATOLOGISK FORSKNING STI
Similar company matching coming soon
We're building AI-powered matching based on industry, size, location, and business model
Discover companies in our directory
Search >100,000 Nordic companies by name, industry, or location
Get the full picture on SKANDINAVISK REVMATOLOGISK FORSKNING STI
Financial history, alerts, outreach tools, and more. Free to use within limits.
Sign up free